The osteogenic-angiogenic interface: Novel insights into the biology of bone formation and fracture repair

Current Osteoporosis Reports

Volumn 6, Issue 2, 2008, Pages 67-71

  Towler, Dwight A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; VASCULOTROPIN; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ANGIOGENESIS; BONE DEVELOPMENT; BONE MARROW CELL; BONE REMODELING; FRACTURE; FRACTURE TREATMENT; HAVERSIAN CANAL; HUMAN; METABOLITE; NONHUMAN; NUTRIENT; OSSIFICATION; OSTEOPOROSIS; OXYGEN SENSING; PARACRINE SIGNALING; REVIEW; TISSUE REPAIR; VASCULARIZATION; BONE; BONE REGENERATION; FRACTURE HEALING; PHYSIOLOGY;

BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; FRACTURE HEALING; FRACTURES, BONE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS;

EID: 58149107786     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-008-0012-x     Document Type: Review

References (43)

1. Woolf AD, Pfleger B: Burden of major musculoskeletal conditions. Bull World Health Organ 2003, 81: 646-656.
2. Zelzer E, McLean W, Ng YS, et al.: Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002, 129: 1893-1904.
3. Carvalho RS, Einhorn TA, Lehmann W, et al.: The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 2004, 34: 849-861.
4. Luo D, Luo Y, He Y, et al.: Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis. Am J Pathol 2006, 169: 1886-1898.
5. He Y, Luo Y, Tang S, et al.: Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J Clin Invest 2006, 116: 2344-2355.
6. Wang Y, Wan C, Deng L, et al.: The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007, 117: 1616-1626.
7. Wan C, Gilbert SR, Wang Y, et al.: Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 2008, 105: 686-691.
8. Zelzer E, Mamluk R, Ferrara N, et al.: VEGFA is necessary for chondrocyte survival during bone development. Development 2004, 131: 2161-2171.
9. Takahashi H, Shibuya M: The vascular endothelial growth factor (VEGF)/ VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 2005, 109: 227-241.
10. Zelzer E, Glotzer DJ, Hartmann C, et al.: Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 2001, 106: 97-106.
11. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12: 5447-5454.
12. Forsythe JA, Jiang BH, Iyer NV, et al.: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996, 16: 4604-4613.
13. Semenza GL: HIF-1, O(2)H and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 2001, 107: 1-3.
14. Jaakkola P, Mole DR, Tian YM, et al.: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
15. Towler DA: Vascular biology andHbone formation: hints from HIF. J Clin Invest 2007, 117:1477-1480.
16. Raaymakers EL: Fractures Af the femoral neck: a review and personal statement. Acta Chir Orthop Traumatol Cech 2006, 73:45-59.
17. Thompson RC Jr, Clohisy DR: Deformity following fracture in diabetic neuropathic osteoarthropathy. Operative management of adults who have type-I diabetes. J Bone Joint Surg Am 1993, 75:1765-1773.
18. Ang E, Black C, Irish J, et al.: Reconstructive options in the treatment of osteoradionecrosis of the craniomaxillofacial skeleton. Br J Plast Surg 2003, 56:92-99.
19. Kalra S, McBryde CW, Lawrence T: Intracapsular hip fractures in end-stage renal failure. Injury 2006, 37:175-184.
20. Damany DS, Parker MJ, Chojnowski A: Complications after intracapsular hip fractures in young adults. A meta-analysis of 18 published studies involving 564 fractures. Injury 2005, 36:131-141.
21. Khosla S, Burr D, Cauley J, et al.: Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007, 22:1479-1491.
22. Aragones J, Schneider M, Van Geyte K, et al.: Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 2008, 40:170-180.
23. Jorgensen NR, Schwarz P, Holme I, et al.: The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: A cross sectional study. Respir Med 2007, 101:177-185.
24. Fei F, Linnosier M, Laroche N, et al.: Chronic hypoxiainduced bone angiogenesis and reduction of bone marrow adipogenesis leads to bone loss in adult rats [abstract]. J Bone Miner Res 2006, 21:SA342.
25. Hauge EM, Qvesel D, Eriksen EF, et al.: Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001, 16:1575-1582.
26. Eriksen EF, Eghbali-Fatourechi GZ, Khosla S: Remodeling and vascular spaces in bone. J Bone Miner Res 2007, 22:1-6.
27. Parfitt AM: The bone remodeAing compartment: a circulatory function for bone lining cells. J Bone Miner Res 2001, 16:1583-1585.
28. Sacchetti B, Funari A, Michienzi S, et al.: Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
29. Shi S, Gronthos S: Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 2003, 18:696-704.
30. Doherty MJ, Ashton BA, Walsh S, et al.: Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 1998, 13:828-838.
31. Kolf CM, Cho E, Tuan RS: Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: Regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007, 9:204.
32. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, et al.: Circulating osteoblast-lineage cells in humans. N Engl J Med 2005, 352:1959-1966.
33. Gazit D, Karmish M, Holzman L, Bab I: Regenerating marrow induces systemic increase in osteo-and chondrogenesis. Endocrinology 1990, 126:2607-2613.
34. Eghbali-Fatourechi GZ, Modder UI, Charatcharoenwitthaya N, et al.: Characterization of circulating osteoblast lineage cells in humans. Bone 2007, 40:1370-1377.
35. Traktuev DO, Merfeld-Clauss S, Li J, et al.: A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008, 102:77-85.
36. Matsumoto T, Kawamoto A, Kuroda R, et al.: Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 2006, 169:1440-1457.
37. Matsumoto T, Mifune Y, Kawamoto A, et al.: Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol 2008, 215:234-242.
38. Zhang H, Bradley A: Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122:2977-2986.
39. Tsuji K, Bandyopadhyay A, Harfe BD, et al.: BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006, 38:1424-1429.
40. Maes C, Coenegrachts L, Stockmans I, et al.: Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 2006, 116:1230-1242.
41. Marrony S, Bassilana F, Seuwen K, Keller H: Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone 2003, 33:426-433.
42. Raida M, Heymann AC, Gunther C, Niederwieser D: Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med 2006, 18:735-739.
43. Peng H, Usas A, Olshanski A, et al.: VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 2005, 20:2017-2027.